Abstract:<p>Methods that enable rapid, sensitive and specific analyses of nucleic acid sequences have positive effects on precise disease diagnostics and effective clinical treatments by providing direct insight into clinically relevant genetic information. Thus far, many CRISPR/Cas systems have been repurposed for diagnostic functions and are revolutionizing the accessibility of robust diagnostic tools due to their high flexibility, sensitivity and specificity. As RNA-guided targeted recognition effectors, Cas9 variants have been utilized for a variety of diagnostic applications, including biosensing assays, imaging assays and target enrichment for next-generation sequencing (NGS), thereby enabling the development of flexible and cost-effective tests. In addition, the ensuing discovery of Cas proteins (Cas12 and Cas13) with collateral cleavage activities has facilitated the development of numerous diagnostic tools for rapid and portable detection, and these tools have great potential for point-of-care settings. However, representative reviews proposed on this topic are mainly confined to classical biosensing applications; thus, a comprehensive and systematic description of this fast-developing field is required. In this review, based on the detection principle, we provide a detailed classification and comprehensive discussion of recent works that harness these CRISPR-based diagnostic tools from a new perspective. Furthermore, current challenges and future perspectives of CRISPR-based diagnostics are outlined.</p>

CRISPR-powered RNA Sensing in Vivo

CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point-of-Care Diagnosis.

Sensing endogenous RNA in living human cells using a CRISPR-activated protease

CRISPR-Cas System for RNA Detection and Imaging

Progress of CRISPR-based programmable RNA manipulation and detection.

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

CRISPR: The Frontier Technology of Next-Generation RNA Detection

High-resolution and programmable RNA-IN and RNA-OUT genetic circuit in living mammalian cells

CRISPR/Cas Systems towards Next-Generation Biosensing

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease

Advancing Sensing Technology with CRISPR: from the Detection of Nucleic Acids to a Broad Range of Analytes – A Review

Progress of CRISPR-Cas13 Mediated Live-Cell RNA Imaging and Detection of RNA-Protein Interactions

[Advances in CRISPR Sensing and Detection Technology].

Reprogrammed Tracrrnas Enable Repurposing of RNAs As Crrnas and Sequence-Specific RNA Biosensors

Engineering Cellular Signal Sensors Based on CRISPR-sgRNA Reconstruction Approaches

RNA-Dependent RNA Targeting by CRISPR-Cas Systems: Characterizations and Applications

Unraveling the Influence of CRISPR/Cas13a Reaction Components on Enhancing Trans-Cleavage Activity for Ultrasensitive On-Chip RNA Detection.

CRISPR-Cas systems: From gene scissors to programmable biosensors